QUADRACEL
NDC 49281-564, diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine, injection, suspension, from Sanofi Vaccines US Inc..
- Product NDC
- 49281-564
- Status
- Listed
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125525
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49281-564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)15 [Lf]/.5mL
- CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf]/.5mL
- BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)20 ug/.5mL
- BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)20 ug/.5mL
- BORDETELLA PERTUSSIS PERTACTIN ANTIGEN3 ug/.5mL
- BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN5 ug/.5mL
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)29 [D'ag'U]/.5mL
- POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)7 [D'ag'U]/.5mL
- POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)26 [D'ag'U]/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Diphtheria Toxoid [CS]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Clostridium Tetani Vaccine [EPC]; Inactivated Corynebacterium Diphtheriae Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Poliovirus Vaccines [CS]; Poliovirus Vaccines [CS]; Poliovirus Vaccines [CS]; Tetanus Toxoid [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49281-564-10 | 49281056410 | 10 VIAL, SINGLE-USE in 1 PACKAGE (49281-564-10) / .5 mL in 1 VIAL, SINGLE-USE (49281-564-58) |
| 49281-564-15 | 49281056415 | 10 SYRINGE in 1 PACKAGE (49281-564-15) / .5 mL in 1 SYRINGE (49281-564-88) |
Linked data
RxNorm, label and prices
RxNorm concepts
- 25870570.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] (SBD)
- 25931210.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Quadracel] (SBD)
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 49281-564 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49281-564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49281-564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.